Autism Numbers Increase by 8.5 Percent in U.S.
According to the U.S. Centers for Disease Control and Prevention (CDC), the number of children diagnosed with autism in the United States continues to increase. In a report published on Mar. 27, 2020, the CDC estimated the prevalence of autism spectrum disorder (ASD) in the country is now 1 in 54 children—up from 1 in […]
Live Tuberculosis “Vaccine” Being Tested as a Treatment for COVID-19 Infections
Story Highlights Researchers at Texas A&M University and five other academic institutions have begun a phase 4 clinical trial re-purposing a live attenuated tuberculosis vaccine to treat COVID-19. The researchers believe that the TICE® BCG vaccine, which is licensed to prevent and treat bladder cancer, may help mitigate the severity of COVID-19. The research team […]
GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant
Story Highlights GlaxoSmithKline and Sanofi Pasteur are partnering to develop an experimental COVID-19 vaccine. The two global vaccine manufacturers are using existing recombinant DNA vaccine technology and a squalene adjuvant for their COVID-19 vaccine. Clinical trials are scheduled to begin in the second half of 2020 and, if successful, the vaccine will be available in […]
Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability
In recent weeks Inovio Pharmaceuticals of Pennsylvania and representatives of the German biotechnology firm CureVac AG and the University of Oxford in the United Kingdom have announced that their experimental COVID-19 vaccines will be ready for use by September 2020. On Apr. 29, 2020, Pfizer, Inc. of New York stated in a news release that […]
COVID-19 Hospitalized Patients and Underlying Chronic Disease
Story Highlights Recent research shows that most hospitalized COVID-19 patients had one or more chronic poor health conditions, such as obesity, hypertension and heart and lung disease. Chronic diseases are the leading cause of death and disability in the United States, making the U.S. population susceptible to more severe COVID-19 infections. Good nutrition helps reduce […]
Inovio COVID-19 Vaccine Uses Electricity to Drive DNA Into Body Cells
Story Highlights Inovio Pharmaceuticals has started Phase 1 testing of its experimental COVID-19 DNA vaccine in healthy volunteers. The U.S. biotech firm has already produced enough of the vaccine to support Phase 1 (immune system reactivity and safety) and Phase 2 (efficacy) testing and plans to have one million doses ready for distribution by the […]